July 1 (Reuters) - Centene Corp CNC.N:
CENTENE CORPORATION WITHDRAWS 2025 GUIDANCE
CENTENE CORP: EXPECTS Q2 2025 MEDICAID HEALTH BENEFITS RATIO TO BE HIGHER THAN Q1 2025 MEDICAID HBR
Source text: ID:nPn6fzXdka
Further company coverage: CNC.N
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.